We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Leptin Reverses Rare Form of Diabetes

By Biotechdaily staff writers
Posted on 21 May 2002
A study has found that the hormone leptin can reverse the symptoms of a rare form of diabetes called lipodystrophy, according to researchers from the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the University of Texas Southwestern Medical Center (Dallas, USA).

People with lipodystrophy have few or no fat cells and therefore lack leptin, a hormone produced by fat cells and stored in them. More...
They are apt to store huge amounts of lipids in muscle or liver, to have very high levels of lipids in their blood, and to be insulin resistant. Eight of the nine female patients in the study had diabetes and were taking either insulin or a diabetes drug or a combination.

Over four months, most patients experienced significant improvements in levels of fasting glucose, or hemoglobin A1c, and triglycerides. They were able to reduce or stop their use of insulin and drugs and reported eating less after treatment. The researchers say these findings suggest that leptin reduces insulin resistance. The study was published in the February 21, 2002, issue of The New England Journal of Medicine.

"This is the first example of leptin's use in a therapeutic role in a rare form of diabetes,” said Philip Gorden, M.D., NIDDK's senior investigator of the study. "The idea is that if people have a hormone deficiency and they are given replacement hormone, they should respond.”


New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.